We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children’s cancer treatment more tailored.
The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.
The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.
Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
Scientists working on the TRACERx project have mapped how the immune systems responds to lung tumours over time
In light of the COVID-19 pandemic and it’s impact on our fundraising, we’ve had to cut our research spend. Here’s everything you need to know.
The Francis Crick Institute’s lab facilities have been temporarily transformed into a COVID-19 testing facility, to help combat the spread of infection.
Researchers have revealed a new blood test that uses artificial intelligence to identify cancer, but it’s not ready for patients yet.